{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:41:33Z","timestamp":1791668493094,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anaphylaxis is a life-threatening hypersensitivity reaction requiring prompt administration of epinephrine. Despite its life-saving role, hesitancy in epinephrine use persists, largely due to concerns about cardiovascular adverse events (AEs). This study aimed to characterize potentially epinephrine-induced cardiovascular AEs in anaphylaxis using data from two major pharmacovigilance databases. A retrospective analysis was conducted using individual case safety reports (ICSRs) from the US FDA Adverse Event Reporting System (FAERS) and the European EudraVigilance database from 2004 to 2024. ICSRs were included if epinephrine was a suspect drug and the indication involved anaphylaxis or related terms. Reports were screened for cardiovascular AEs and assessed for causality by two independent reviewers. Descriptive statistics were used to summarize findings. A total of 802 and 517 ICSRs were analyzed from FAERS and EudraVigilance, respectively. Cardiovascular AEs were reported in 142 and 134 ICSRs, respectively, with epinephrine as the sole suspect in most cases. Female patients were more frequently represented. Stress cardiomyopathy, myocardial ischemia, tachycardia, and acute myocardial infarction were the most common cardiovascular AEs. Intravenous administration was frequently associated with serious outcomes. Causality assessment indicated that a majority of cardiovascular AEs were likely related to epinephrine. Cardiovascular AEs, particularly stress cardiomyopathy, are associated with epinephrine use in anaphylaxis, especially when administered intravenously. While these findings support cautious use, they also highlight the importance of adhering to recommended intramuscular administration to minimize preventable risks. Clinician awareness and adherence to guidelines remain critical for safe and effective anaphylaxis management, prioritizing cautious use over hesitancy.<\/jats:p>","DOI":"10.1038\/s41598-025-20999-3","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:45:13Z","timestamp":1761219913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Study of epinephrine-induced cardiovascular adverse events in patients with anaphylaxis using two spontaneously reported adverse event databases from 2004 to 2024"],"prefix":"10.1038","volume":"15","author":[{"given":"Priyanka","family":"Kamath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi R.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"20999_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12016-015-8503-x","volume":"54","author":"JE Yu","year":"2018","unstructured":"Yu, J. E. & Lin, R. Y. The epidemiology of anaphylaxis. Clin. Rev. Allergy Immunol. 54, 366\u2013374. https:\/\/doi.org\/10.1007\/s12016-015-8503-x (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"20999_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","volume":"97","author":"P Lieberman","year":"2006","unstructured":"Lieberman, P. et al. Epidemiology of anaphylaxis: findings of the American college of Allergy, asthma and immunology epidemiology of anaphylaxis working group. Ann. Allergy Asthma Immunol. 97, 596\u2013602. https:\/\/doi.org\/10.1016\/S1081-1206(10)61086-1 (2006).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"20999_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.iac.2021.09.005","volume":"42","author":"A Navalpakam","year":"2022","unstructured":"Navalpakam, A., Thanaputkaiporn, N. & Poowuttikul, P. Management of anaphylaxis. Immunol. Allergy Clin. North. Am. 42, 65\u201376. https:\/\/doi.org\/10.1016\/j.iac.2021.09.005 (2022).","journal-title":"Immunol. Allergy Clin. North. Am."},{"key":"20999_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/PEC.0b013e31818ea116","volume":"24","author":"DB Liberman","year":"2008","unstructured":"Liberman, D. B. & Teach, S. J. Management of anaphylaxis in children. Pediatr. Emerg. Care. 24, 861\u2013866. https:\/\/doi.org\/10.1097\/PEC.0b013e31818ea116 (2008). quiz 867\u20139.","journal-title":"Pediatr. Emerg. Care"},{"key":"20999_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaip.2013.08.012","volume":"2","author":"A Banerji","year":"2014","unstructured":"Banerji, A. et al. Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. J. Allergy Clin. Immunol. Pract. 2, 46\u201351. https:\/\/doi.org\/10.1016\/j.jaip.2013.08.012 (2014).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"20999_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MEJ.0000000000000155","volume":"22","author":"EA Hitti","year":"2015","unstructured":"Hitti, E. A., Zaitoun, F., Harmouche, E., Saliba, M. & Mufarrij, A. Acute allergic reactions in the emergency department: characteristics and management practices. Eur. J. Emerg. Med. 22, 253\u2013259. https:\/\/doi.org\/10.1097\/MEJ.0000000000000155 (2015).","journal-title":"Eur. J. Emerg. Med."},{"key":"20999_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaip.2019.12.015","volume":"8","author":"JC Brown","year":"2020","unstructured":"Brown, J. C., Simons, E. & Rudders, S. A. Epinephrine in the management of anaphylaxis. J. Allergy Clin. Immunol. Pract. 8, 1186\u20131195. https:\/\/doi.org\/10.1016\/j.jaip.2019.12.015 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"20999_CR8","doi-asserted-by":"publisher","unstructured":"Leiser, A., Virdee, R. & Kinniry, P.  Severe Epinephrine-Induced Lactic Acidosis. B37. Critical lab value alert; Hormones and electrolytes in the ICU.  A3414\u2013A3414 (American Thoracic Society, 2024). https:\/\/doi.org\/10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A3414.","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A3414"},{"key":"20999_CR9","doi-asserted-by":"publisher","first-page":"40065","DOI":"10.57187\/smw.2023.40065","volume":"153","author":"S Ehrhard","year":"2023","unstructured":"Ehrhard, S. et al. Use of epinephrine in anaphylaxis: a retrospective cohort study at a Swiss university emergency department. Swiss Med. Wkly. 153, 40065. https:\/\/doi.org\/10.57187\/smw.2023.40065 (2023).","journal-title":"Swiss Med. Wkly."},{"key":"20999_CR10","doi-asserted-by":"publisher","first-page":"1163817","DOI":"10.3389\/fmed.2023.1163817","volume":"10","author":"Y-Y Lin","year":"2023","unstructured":"Lin, Y-Y. et al. Investigation of the underuse of adrenaline (epinephrine) and prognosis among patients with anaphylaxis at emergency department admission. Front. Med. (Lausanne). 10, 1163817. https:\/\/doi.org\/10.3389\/fmed.2023.1163817 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"20999_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.resuscitation.2016.12.020","volume":"112","author":"T Kawano","year":"2017","unstructured":"Kawano, T. et al. Epinephrine use in older patients with anaphylaxis: clinical outcomes and cardiovascular complications. Resuscitation 112, 53\u201358. https:\/\/doi.org\/10.1016\/j.resuscitation.2016.12.020 (2017).","journal-title":"Resuscitation"},{"key":"20999_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.04.001","volume":"4","author":"JP Wood","year":"2013","unstructured":"Wood, J. P., Traub, S. J. & Lipinski, C. Safety of epinephrine for anaphylaxis in the emergency setting. World J. Emerg. Med. 4, 245\u2013251. https:\/\/doi.org\/10.5847\/wjem.j.issn.1920-8642.2013.04.001 (2013).","journal-title":"World J. Emerg. Med."},{"key":"20999_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1067\/mai.2001.119409","volume":"108","author":"FE Simons","year":"2001","unstructured":"Simons, F. E., Gu, X. & Simons, K. J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J. Allergy Clin. Immunol. 108, 871\u2013873. https:\/\/doi.org\/10.1067\/mai.2001.119409 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"key":"20999_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","volume":"82","author":"J Motiejunaite","year":"2021","unstructured":"Motiejunaite, J., Amar, L. & Vidal-Petiot, E. Adrenergic receptors and cardiovascular effects of catecholamines. Ann. Endocrinol. (Paris). 82, 193\u2013197. https:\/\/doi.org\/10.1016\/j.ando.2020.03.012 (2021).","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"20999_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13054-018-2058-1","volume":"22","author":"CJR Gough","year":"2018","unstructured":"Gough, C. J. R. & Nolan, J. P. The role of adrenaline in cardiopulmonary resuscitation. Crit. Care. 22, 139. https:\/\/doi.org\/10.1186\/s13054-018-2058-1 (2018).","journal-title":"Crit. Care"},{"key":"20999_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/08998280.2019.1634229","volume":"32","author":"S Bhat","year":"2019","unstructured":"Bhat, S., Gazi, H., Mwansa, V. & Chhabra, L. Catecholamine-induced reverse Takotsubo cardiomyopathy. Proc. (Bayl Univ. Med. Cent). 32, 567\u2013569. https:\/\/doi.org\/10.1080\/08998280.2019.1634229 (2019).","journal-title":"Proc. (Bayl Univ. Med. Cent)"},{"key":"20999_CR17","doi-asserted-by":"publisher","first-page":"2050313X2311597","DOI":"10.1177\/2050313X231159732","volume":"11","author":"G Pathangey","year":"2023","unstructured":"Pathangey, G., Moudgal, R., Lee, C. & Henkin, S. Myocardial stunning secondary to erroneous administration of intravenous epinephrine. SAGE Open. Med. Case Rep. 11, 2050313X231159732. https:\/\/doi.org\/10.1177\/2050313X231159732 (2023).","journal-title":"SAGE Open. Med. Case Rep."},{"key":"20999_CR18","doi-asserted-by":"publisher","first-page":"e932028","DOI":"10.12659\/AJCR.932028","volume":"22","author":"W Yamamoto","year":"2021","unstructured":"Yamamoto, W. et al. Takotsubo cardiomyopathy induced by very Low-Dose epinephrine contained in local anesthetics: A case report. Am. J. Case Rep. 22, e932028. https:\/\/doi.org\/10.12659\/AJCR.932028 (2021).","journal-title":"Am. J. Case Rep."},{"key":"20999_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2016.11.266","volume":"229","author":"S Nazir","year":"2017","unstructured":"Nazir, S. et al. Takotsubo cardiomyopathy associated with epinephrine use: A systematic review and meta-analysis. Int. J. Cardiol. 229, 67\u201370. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.266 (2017).","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"20999_CR20","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","volume":"13","author":"V Cardona","year":"2020","unstructured":"Cardona, V. et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ. J. 13 (10), 100472. https:\/\/doi.org\/10.1016\/j.waojou.2020.100472 (2020).","journal-title":"World Allergy Organ. J."},{"issue":"4","key":"20999_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7861\/clinmed.2022-0073","volume":"22","author":"AF Whyte","year":"2022","unstructured":"Whyte, A. F. et al. Emergency treatment of anaphylaxis: concise clinical guidance. Clin. Med. (Lond). 22 (4), 332\u2013339. https:\/\/doi.org\/10.7861\/clinmed.2022-0073 (2022).","journal-title":"Clin. Med. (Lond)"},{"key":"20999_CR22","unstructured":"ASCIA Guidelines Acute management of anaphylaxis - Australasian Society of Clinical Immunology and Allergy (ASCIA). https:\/\/www.allergy.org.au\/hp\/papers\/acute-management-of-anaphylaxis-guidelines. Accessed 10 Aug 2025."},{"issue":"2","key":"20999_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","volume":"132","author":"DBK Golden","year":"2024","unstructured":"Golden, D. B. K. et al. A 2023 practice parameter update. Ann. Allergy Asthma Immunol. 132 (2), 124\u2013176. https:\/\/doi.org\/10.1016\/j.anai.2023.09.015 (2024).","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"982","key":"20999_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/pgmj.2007.058776","volume":"83","author":"R Ramaraj","year":"2007","unstructured":"Ramaraj, R. Stress cardiomyopathy: aetiology and management. Postgrad. Med. J. 83 (982), 543\u2013546. https:\/\/doi.org\/10.1136\/pgmj.2007.058776 (2007).","journal-title":"Postgrad. Med. J."},{"key":"20999_CR25","unstructured":"Epinephrine Injection USP. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/205029s006lbl.pdf. Accessed 10 Aug 2025."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20999-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:45:15Z","timestamp":1761219915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20999-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20999"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20999-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author is an editorial board member of Scientific Reports. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Institutional Ethics Committee, Kasturba Medical College, Mangalore (20 February 2025, IECKMCMLR02\/2025\/57). Consent to participate is not applicable since the study used anonymized data from publicly accessible adverse event databases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"37088"}}